Department of Psychiatry, Yale University School of Medicine, 34 Park St. -S205, New Haven, CT 06519, USA.
Drug Alcohol Depend. 2011 Oct 1;118(1):48-55. doi: 10.1016/j.drugalcdep.2011.02.019. Epub 2011 Mar 31.
Cocaine abuse among women of child-bearing years is a significant public health problem. This study evaluated the efficacy of contingency management (CM), the community reinforcement approach (CRA), and twelve-step facilitation (TSF) for cocaine-dependent pregnant women or women with young children.
Using a 2×2 study design, 145 cocaine dependent women were randomized to 24 weeks of CRA or TSF and to monetary vouchers provided contingent on cocaine-negative urine tests (CM) or non-contingently but yoked in value (voucher control, VC). Primary outcome measures included the longest consecutive period of documented abstinence, proportion of cocaine-negative urine tests (obtained twice-weekly), and percent days using cocaine (PDC) during treatment. Documented cocaine abstinence at baseline and 3, 6, 9 and 12 months following randomization was a secondary outcome.
CM was associated with significantly greater duration of cocaine abstinence (p<.01), higher proportion of cocaine-negative urine tests (p<0.01), and higher proportion of documented abstinence across the 3-, 6-, 9- and 12-month assessments (p<0.05), compared to VC. The differences between CRA and TSF were not significant for any of these measures (all p values ≥0.75). PDC decreased significantly from baseline during treatment in all four groups (p<0.001) but did not differ significantly between CM and VC (p=0.10) or between TSF and CRA (p=0.23).
The study findings support the efficacy of CM for cocaine dependent pregnant women and women with young children but do not support greater efficacy of CRA compared to TSF or differential efficacy of CM when paired with either CRA or TSF.
育龄期可卡因滥用是一个重大的公共卫生问题。本研究评估了基于强化的社区治疗(CRA)、药物使用契约(CM)和十二步康复法(TSF)对可卡因依赖的孕妇或有年幼子女的妇女的疗效。
采用 2×2 设计,将 145 名可卡因依赖的女性随机分为 24 周的 CRA 或 TSF 组,并分为基于尿液可卡因阴性检测结果的金钱奖励组(CM)或非条件但价值与 CM 相匹配的奖励组(VC)。主要结局指标包括最长连续无可卡因使用时间、可卡因阴性尿液检测比例(每两周检测一次)和治疗期间可卡因使用日数(PDC)。在随机分组前和随机分组后 3、6、9 和 12 个月时的可卡因使用记录作为次要结局。
与 VC 相比,CM 显著延长了可卡因使用的持续时间(p<.01),提高了可卡因阴性尿液检测的比例(p<0.01),并且在 3、6、9 和 12 个月的评估中,记录的完全戒断率更高(p<0.05)。与 CRA 相比,CM 在这些指标上的差异均无统计学意义(所有 p 值≥0.75)。在所有 4 组中,PDC 在治疗期间均较基线显著下降(p<0.001),但 CM 与 VC 之间无显著差异(p=0.10),CM 与 CRA 之间也无显著差异(p=0.23)。
本研究结果支持 CM 对可卡因依赖的孕妇和有年幼子女的妇女的疗效,但不支持 CRA 比 TSF 更有效,也不支持 CM 与 CRA 或 TSF 配对使用时的疗效差异。